VDR and Cowden disease: These findings suggest that the characterization of VDR polymorphisms may help clinicians better predict the risk of CD complications and optimize treatment, including VD supplementation, which has been shown to restore the reduced VDR protein levels detected in fibroblasts from CD patients [27], including those carrying the TaqI polymorphism [17].